EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS

Аppearance of a malignant tumor is associated with impaired mechanisms of proliferation, differentiation, apoptosis ability. However, these changes are not enough for immune system to recognize and destroy mutated cells. Weak immunogenicity of tumor-associated antigens (TAA) and the insufficiency of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A. B. Dorzhieva, T. S. Khabalova, Yu. E. Androsova, E. A. Kaschenko, I. P. Ivanova, G. V. Seledtsova
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2021
Materias:
Acceso en línea:https://doaj.org/article/60aec8e12b0247809952f78a60b6773d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:60aec8e12b0247809952f78a60b6773d
record_format dspace
spelling oai:doaj.org-article:60aec8e12b0247809952f78a60b6773d2021-11-18T08:03:51ZEFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS1563-06252313-741X10.15789/1563-0625-EOT-2299https://doaj.org/article/60aec8e12b0247809952f78a60b6773d2021-10-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/2299https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XАppearance of a malignant tumor is associated with impaired mechanisms of proliferation, differentiation, apoptosis ability. However, these changes are not enough for immune system to recognize and destroy mutated cells. Weak immunogenicity of tumor-associated antigens (TAA) and the insufficiency of co-stimulating molecules on the surface of tumor cells is a reason for this phenomenon Since biochemical processes of tumor cells and healthy tissue cells are identical, therefore creation of effective chemotherapeutic drugs is limited not by selectivity of their action. So antitumor vaccination is the most effective specific method for both preventing recurrence of a disease and a therapeutic treatment tool in oncology. Xenogeneic proteins are highly immunogenic and effective in breaking immune tolerance to human analogs. In our work, we used sheep testicular AG as a source xenogenic TAAs. Sheep testicles contain a large set of TAAs. Experimental mice were immunized with type liposomal testicular vaccine from sheep, one month after vaccination, to induce tumor growth, cells of carcinoma LLC were implanted in mouse. The life expectancy of the experimental group of mice was 2 times higher compared to the syngenetic control and 20% of them did not develop the tumor at all. In the spleen of mice who did not have tumors after pre-vaccination sheep liposomal testicular AG, T-regulatory cells and T-memory cells were measured. We found a credible decrease in both naive Treg (CD4+CD25+), activated (CD4+CD25+FoxP3+) and both T-memory (CD4+CD44+) and central memory (CD4+CD44+CD62L+) in spleen pre-vaccination mice with compared to the contral intact spleen. Content of IFNg and IL-10 in supernatants of mouse slenocytes derived from vaccinated mice with no tumors was investigated and showed a reliable decrease in the amount of IL-10, but not IFNg. We believe that immunization with xenogenic tumor AGs can lead to the formation of a protective antitumor response.A. B. DorzhievaT. S. KhabalovaYu. E. AndrosovaE. A. KaschenkoI. P. IvanovaG. V. SeledtsovaSPb RAACIarticlecancer vaccineslewis lung carcinoma (llc)tumor-specific antigenstestis antigensimmunotherapyimmune responseImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 23, Iss 4, Pp 665-670 (2021)
institution DOAJ
collection DOAJ
language RU
topic cancer vaccines
lewis lung carcinoma (llc)
tumor-specific antigens
testis antigens
immunotherapy
immune response
Immunologic diseases. Allergy
RC581-607
spellingShingle cancer vaccines
lewis lung carcinoma (llc)
tumor-specific antigens
testis antigens
immunotherapy
immune response
Immunologic diseases. Allergy
RC581-607
A. B. Dorzhieva
T. S. Khabalova
Yu. E. Androsova
E. A. Kaschenko
I. P. Ivanova
G. V. Seledtsova
EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
description Аppearance of a malignant tumor is associated with impaired mechanisms of proliferation, differentiation, apoptosis ability. However, these changes are not enough for immune system to recognize and destroy mutated cells. Weak immunogenicity of tumor-associated antigens (TAA) and the insufficiency of co-stimulating molecules on the surface of tumor cells is a reason for this phenomenon Since biochemical processes of tumor cells and healthy tissue cells are identical, therefore creation of effective chemotherapeutic drugs is limited not by selectivity of their action. So antitumor vaccination is the most effective specific method for both preventing recurrence of a disease and a therapeutic treatment tool in oncology. Xenogeneic proteins are highly immunogenic and effective in breaking immune tolerance to human analogs. In our work, we used sheep testicular AG as a source xenogenic TAAs. Sheep testicles contain a large set of TAAs. Experimental mice were immunized with type liposomal testicular vaccine from sheep, one month after vaccination, to induce tumor growth, cells of carcinoma LLC were implanted in mouse. The life expectancy of the experimental group of mice was 2 times higher compared to the syngenetic control and 20% of them did not develop the tumor at all. In the spleen of mice who did not have tumors after pre-vaccination sheep liposomal testicular AG, T-regulatory cells and T-memory cells were measured. We found a credible decrease in both naive Treg (CD4+CD25+), activated (CD4+CD25+FoxP3+) and both T-memory (CD4+CD44+) and central memory (CD4+CD44+CD62L+) in spleen pre-vaccination mice with compared to the contral intact spleen. Content of IFNg and IL-10 in supernatants of mouse slenocytes derived from vaccinated mice with no tumors was investigated and showed a reliable decrease in the amount of IL-10, but not IFNg. We believe that immunization with xenogenic tumor AGs can lead to the formation of a protective antitumor response.
format article
author A. B. Dorzhieva
T. S. Khabalova
Yu. E. Androsova
E. A. Kaschenko
I. P. Ivanova
G. V. Seledtsova
author_facet A. B. Dorzhieva
T. S. Khabalova
Yu. E. Androsova
E. A. Kaschenko
I. P. Ivanova
G. V. Seledtsova
author_sort A. B. Dorzhieva
title EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
title_short EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
title_full EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
title_fullStr EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
title_full_unstemmed EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
title_sort efficiency of the formation of antitumor immune responses in the system of preventive vaccination of mice with testicular antigens
publisher SPb RAACI
publishDate 2021
url https://doaj.org/article/60aec8e12b0247809952f78a60b6773d
work_keys_str_mv AT abdorzhieva efficiencyoftheformationofantitumorimmuneresponsesinthesystemofpreventivevaccinationofmicewithtesticularantigens
AT tskhabalova efficiencyoftheformationofantitumorimmuneresponsesinthesystemofpreventivevaccinationofmicewithtesticularantigens
AT yueandrosova efficiencyoftheformationofantitumorimmuneresponsesinthesystemofpreventivevaccinationofmicewithtesticularantigens
AT eakaschenko efficiencyoftheformationofantitumorimmuneresponsesinthesystemofpreventivevaccinationofmicewithtesticularantigens
AT ipivanova efficiencyoftheformationofantitumorimmuneresponsesinthesystemofpreventivevaccinationofmicewithtesticularantigens
AT gvseledtsova efficiencyoftheformationofantitumorimmuneresponsesinthesystemofpreventivevaccinationofmicewithtesticularantigens
_version_ 1718422287944777728